87628-0101 Varubi - CanMED: NDC

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

87628-0101

Brand Name:

Varubi

Generic Name:

Rolapitant

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: ROLAPITANT HYDROCHLORIDE

Strength: 90.0

Unit: mg/1

Packages:

Code: 87628-0101-02

Description: 2 TABLET in 1 BLISTER PACK (87628-101-02)

Effective Date: Sept. 8, 2026

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

Substance P/Neurokinin 1

Orphan Drug Designation:

Status:

In Use